Archives
Novel gene therapy for hemophilia A leads to sustained expression of clotting factor and reduced bleeding events.
19 Nov, 2021 | 10:25h | UTCOriginal Study: Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A – New England Journal of Medicine
Commentary on Twitter
3.5 years after therapy with factor VIII-containing adeno-associated virus, 16 of 18 men with hemophilia A had enough factor VIII expression that bleeding events were reduced to nearly zero and prophylaxis was discontinued. https://t.co/n3cPyjGDkn pic.twitter.com/vPyz0OmT1S
— NEJM (@NEJM) November 18, 2021
M-A: Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality.
18 Nov, 2021 | 08:59h | UTC
Commentary on Twitter
Experts call for continued use of personal protective and social measures alongside covid-19 vaccination in @bmj_latest today https://t.co/MOT4O2R6Ui pic.twitter.com/dAxhStSxpJ
— BMJ Group (@bmj_company) November 18, 2021
Long-term results of RCT: Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer.
19 Nov, 2021 | 10:15h | UTCChemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Author Interview: Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer – JAMA Oncology
Commentary on Twitter
Secondary analysis of 311 pts on ARO-12 trial of variant approaches to total neoadjuvant therapy (TNT) w/combo of chemo & concurrent chemoradiation (CRT) for rectal cancer shows best results w/up-front CRT then chemo & resection led to best results https://t.co/7cpv5cb1Fr #CRCSM pic.twitter.com/bxfz9Fi5OB
— JAMA Oncology (@JAMAOnc) November 18, 2021
Review: Should children under 12 years of age be vaccinated against COVID-19?
18 Nov, 2021 | 08:56h | UTCShould children be vaccinated against COVID-19? – Archives of Disease in Childhood
Commentary from the author on Twitter (thread – click for more)
Should #children be vaccinated against #COVID19?
Our review outlines the points to consider in weighing up whether all healthy children under 12y should be vaccinated against COVID-19.https://t.co/JtoOr2TZoq#medpeds #IDTwitter #PaedsID #tweetiatrician #paediatrics
🧵1/n pic.twitter.com/g4UGu3pMsE
— Nigel Curtis (@nigeltwitt) November 6, 2021
Review: Treatment selection in first-line metastatic renal cell carcinoma—the contemporary treatment paradigm in the age of combination therapy.
19 Nov, 2021 | 10:14h | UTCTreatment Selection in First-line Metastatic Renal Cell Carcinoma—The Contemporary Treatment Paradigm in the Age of Combination Therapy: A Review – JAMA Oncology (free for a limited period)
Covid: Children in UK told to delay jab for 12 weeks after infection.
18 Nov, 2021 | 08:54h | UTCCovid: Children told to delay jab for 12 weeks after infection – BBC
Original Report: Joint Committee on Vaccination and Immunisation (JCVI) advice on COVID-19 vaccination in people aged 16 to 17 years: 15 November 2021
Observational study finds mRNA vaccination is associated with an effectiveness of 85% against Covid-19 hospitalization.
18 Nov, 2021 | 08:49h | UTCAssociation Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity – JAMA
Editorial: Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination – JAMA
Commentary: COVID-19 vaccines 85% effective against hospital cases but weaken over time – TCTMD
Related Study: Study compares the decline in effectiveness for Moderna, Pfizer, and Janssen vaccines and consequences for mortality.
[Preprint] M-A: Inhaled corticosteroids in COVID-19 outpatients.
18 Nov, 2021 | 08:48h | UTCInhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis – medRxiv
Commentary: Favourable meta-analysis of inhaled corticosteroids in COVID-19 outpatients – News Medical
Related:
Position Paper: Recommendations for the use of topical inhalant budesonide in COVID-19.
RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19
Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19
Commentary on Twitter
The first meta-analysis of the 4 completed & reported trials of outpatient inhaled corticosteroid #COVID19 treatment
The results support the use of inhaled corticosteroids (ciclesonide or budesonide) for the resolution of symptoms at day 14 of treatmenthttps://t.co/KnBDKhfYmi pic.twitter.com/WSd9htXwe4— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) November 5, 2021
Observational study finds the effectiveness of mRNA vaccination against Covid-19 hospitalization was lower (77%) among immunocompromised adults than among immunocompetent adults (90%).
18 Nov, 2021 | 08:52h | UTCRelated:
CDC Guidance: Immunocompromised may need a fourth Covid-19 shot.
Commentary on Twitter (thread – click for more)
New CDC study of mRNA #vaccination & disease in 89,000 ppl hospitalized w/#COVID19
– 69K had normal immune systems; 1/2 of them were 2-dose vaxed
– 20K had systs weakened by cancer or other illnesses, 25% of whom were unvaxed
– Vax was 90% effective in preventing severe…
MORE pic.twitter.com/w3RFCrQnLB— Laurie Garrett (@Laurie_Garrett) November 2, 2021
8 lingering questions about the new Covid pills from Merck and Pfizer.
18 Nov, 2021 | 08:46h | UTC8 lingering questions about the new Covid pills from Merck and Pfizer – STAT
Related:
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.
Merck to allow other nations to produce new COVID-19 antiviral.
Video: Merck’s Covid pill could transform treatment. Here’s how it works.
How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.
What we know — and don’t know — about Merck’s new Covid-19 pill.
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.
Observational study in patients with stroke with large-vessel occlusion presenting in the extended window suggests non-contrast CT is as good as CT perfusion or MRI to select patients for thrombectomy.
18 Nov, 2021 | 08:41h | UTCCommentary: Noncontrast CT a cost-friendly alternative to select late-stroke patients for thrombectomy – Health Imaging
Commentary on Twitter
Don’t have CTP worry not! No MRI/MRP worry not! Good old non-contrast CTH performs just as well for pt selection! But I do like those colored CBF, CBV, MTT maps & don’t like the errors in image processing! This will inc access to late thrombectomy #NoELVOleftbehind @almuftifawaz https://t.co/vBv5y2IDjT
— Neha Dangayach MD MSCR FAAN FANA FCCP FCCM FNCS (@drdangayach) November 11, 2021
NICE Guideline | Heart valve disease presenting in adults: investigation and management.
18 Nov, 2021 | 08:44h | UTCRelated Guidelines:
2020 ACC/AHA Guideline for the management of patients with valvular heart disease
RCT: An exercise program reduced upper limb disability one year after non-reconstructive breast cancer surgery.
18 Nov, 2021 | 08:39h | UTCCommentaries:
Exercise reduces upper limb disability after breast cancer surgery – BMJ / News Medical
Exercise Helps Ease Arm, Shoulder Pain After Breast Cancer Surgery- HealthDay
Structured Exercise Improves Upper Limb Function After Breast Ca Surgery – Physician’s Weekly
Commentary on Twitter
Women who exercise shortly after having non-reconstructive breast cancer surgery appear to regain better shoulder and arm mobility and experience less pain than those who receive standard care, finds this study @jxbruce https://t.co/BhIKb8RRjV
— The BMJ (@bmj_latest) November 11, 2021
M-A: In patients with anterior circulation acute stroke and evidence of reversible cerebral ischemia across the 6–24 h time window, thrombectomy was associated with higher rates of independence in activities of daily living at 90 days than best medical therapy alone.
18 Nov, 2021 | 08:43h | UTCThrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis – The Lancet (link to abstract – $ for full-text)
Editorial: Twenty recommendations to individualize interventions in the early resuscitation of patients with sepsis.
18 Nov, 2021 | 08:38h | UTCRelated: Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.
Review: A fresh look at coronary microembolization.
18 Nov, 2021 | 08:35h | UTCA fresh look at coronary microembolization – Nature Reviews Cardiology (if this link is paywalled, try this one)
Commentary on Twitter
In our latest Review, @PKleinbongard and Gerd Heusch take a fresh look at coronary microembolization and how it can be prevented and treated https://t.co/OLlcfGO6Ui pic.twitter.com/U5Qlg6Blqd
— Nature Reviews Cardiology (@NatRevCardiol) November 17, 2021
Demystifying the EEG report for intensivists.
18 Nov, 2021 | 08:36h | UTCDemystifying the EEG Report – NeuroEMCrit
Podcast | Liver emergencies: acute liver failure, hepatic encephalopathy, hepatorenal syndrome, liver test interpretation & drugs to avoid.
18 Nov, 2021 | 08:32h | UTCLiver Emergencies: Acute Liver Failure, Hepatic Encephalopathy, Hepatorenal Syndrome, Liver Test Interpretation & Drugs to Avoid – Emergency Medicines Cases (text summary and podcast)
What Is the best maintenance therapy for ANCA vasculitis?
18 Nov, 2021 | 08:34h | UTC
RCT: In Infants with infantile hemangioma, nadolol is noninferior to propranolol and may be an efficacious and safe alternative in cases of propranolol unresponsiveness or adverse events.
18 Nov, 2021 | 08:29h | UTCCommentary: Oral Nadolol Feasible for the Treatment of Infantile Hemangiomas – HealthDay
Commentary on Twitter
A randomized clinical trial found #nadolol is non-inferior to #propranolol in patients with infantile hemangioma—a safe and efficacious alternative when fast response is needed https://t.co/ECVFfFPBJ2
— JAMA Pediatrics (@JAMAPediatrics) November 9, 2021
New ACR radiation diagnostic reference levels for top 10 pediatric CT exams.
18 Nov, 2021 | 08:31h | UTCNews Release: New Radiation Diagnostic Reference Levels for Top 10 Pediatric CT Exams – American College of Radiology
Original Guideline: U.S. Diagnostic Reference Levels and Achievable Doses for 10 Pediatric CT Examinations – Radiology
Commentary: ACR releases new benchmarks to help radiology departments optimize radiation dose levels – Health Imaging
Case-control study: sleep disorders linked to more severe outcomes from COVID-19, study suggests.
17 Nov, 2021 | 08:50h | UTCNews Release: Sleep disorders linked with more severe outcomes from COVID-19, study suggests – Cleveland Clinic
Commentary: Some sleep disorders may lead to worse COVID-19 outcomes – CIDRAP
Commentary on Twitter
This case-control study found that among patients infected with #SARSCoV2, sleep-related hypoxia was an associated risk factor for detrimental #COVID19 outcomes. https://t.co/oWjPxBSxT8
— JAMA Network Open (@JAMANetworkOpen) November 10, 2021
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic.
17 Nov, 2021 | 08:56h | UTCESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic – European Heart Journal
Part 1—epidemiology, pathophysiology, and diagnosis
Part 2—care pathways, treatment, and follow-up
News release: European Society of Cardiology COVID-19 guidance launched – European Society of Cardiology
Commentaries on Twitter
New: @escardio guidance for the diagnosis and management of #CardiovascularDisease during the #COVID19 pandemic: Part 1 – Epidemiology, pathophysiology and diagnosis https://t.co/8yGWQ5qgPT#cardiotwitter #cardiology #ESCYoung #ESCSoT #heartteam #cvnurses #alliedprofessionals pic.twitter.com/5YM4DDjzGW
— European Society of Cardiology (@escardio) November 16, 2021
NEW: @escardio guidance for the diagnosis and management of #CardiovascularDisease during the #COVID19 pandemic: part 2—care pathways, treatment, and follow-up https://t.co/6DkVWWjZY6#cardiotwitter #ESCYoung #ESCSoT #heartteam #cvnurses #alliedprofessionals #cardiology pic.twitter.com/yC6PD8a1hS
— European Society of Cardiology (@escardio) November 16, 2021
Systematic Review: Multidisciplinary rehabilitation for older people with hip fractures.
18 Nov, 2021 | 08:28h | UTCOriginal Study: Multidisciplinary rehabilitation for older people with hip fractures – Cochrane Library
Commentary on Twitter
JUST PUBLISHED – Multidisciplinary #rehabilitation for older people with hip fractures ➡️ https://t.co/kjhycTCjE8 Updated @CochraneBJMT systematic review looks at the evidence from 28 trials involving 5,351. @CochraneRehab @CCGlobalAgeing #rehab pic.twitter.com/ZamV4xHObh
— The Cochrane Library (@CochraneLibrary) November 12, 2021
Observational study found monitoring outpatients with Covid-19 using text messages that allowed the report of worsening symptoms was associated with improved outcomes.
17 Nov, 2021 | 08:53h | UTCNews Release: Automated Texting System Saved Lives Weekly During First COVID Surge – Penn Medicine
Commentaries:
Monitoring outpatients by text appeared to reduce mortality from COVID-19 – ACP Internist
Texting saved lives during Covid. What does that mean for health care’s future? – STAT
Commentary from the author on Twitter (thread – click for more)
1/ For the >80,000 people in the U.S who will test positive for #Covid19 today, what can we offer to support access to care but help them safely remain at home?
Our team is excited to finally share important, new findings out today in @AnnalsofIM
👉https://t.co/VOtpucwWGD pic.twitter.com/UbNRP5bnW4— M. Kit Delgado, MD, MS (@kit_delgadoMD) November 16, 2021


